Essex Savings Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Buy
2,816
+200
+8% +$37.6K 0.12% 176
2026
Q1
$516K Buy
2,616
+54
+2% +$10.4K 0.11% 162
2025
Q4
$471K Sell
2,562
-20
-0.8% -$3.51K 0.1% 175
2025
Q3
$396K Sell
2,582
-85
-3% -$12.9K 0.09% 185
2025
Q2
$373K Sell
2,667
-219
-8% -$30.7K 0.09% 189
2025
Q1
$424K Buy
2,886
+96
+3% +$13.9K 0.1% 172
2024
Q4
$366K Sell
2,790
-125
-4% -$17.5K 0.09% 182
2024
Q3
$454K Buy
2,915
+191
+7% +$30.8K 0.11% 158
2024
Q2
$425K Buy
+2,724
New +$410K 0.11% 158
2019
Q3
Sell
-415
Closed -$34K 213
2019
Q2
$34K Buy
415
+365
+730% +$28.6K 0.01% 497
2019
Q1
$4K Sell
50
-28
-36% -$2.21K ﹤0.01% 570
2018
Q4
$6K Buy
+78
New +$6.09K ﹤0.01% 546

Other funds holding AZN

Essex Savings Bank's AZN Position: Q2 2026 in Review

Essex Savings Bank increased its AstraZeneca (AZN) stake by 7.6% in Q2 2026, buying an estimated $37.6K and bringing the position to 2,816 shares worth $534K. The position accounts for 0.12% of the portfolio, ranked #176.

Essex Savings Bank first reported a position in AZN in Q4 2018 and has held it in 12 quarters since. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Essex Savings Bank held 2,816 shares of AstraZeneca worth $534K as of Q2 2026.
  • Essex Savings Bank bought 200 AstraZeneca shares in Q2 2026, an estimated $37.6K.
  • AstraZeneca made up 0.12% of Essex Savings Bank's portfolio in Q2 2026, its #176 holding.
  • Essex Savings Bank first reported a position in AstraZeneca in Q4 2018 and has held it in 12 quarters since.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Essex Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.